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ABSTRACT 29 
Global transcriptional regulators that respond to specific environmental 30 
signals are crucial in bacterial pathogenesis. In the case of the Gram-positive 31 
pathogen Streptococcus pneumoniae (the pneumococcus), the sp1800 gene of 32 
the clinical isolate TIGR4 encodes a protein that exhibits homology to the Mga 33 
‘stand-alone’ response regulator of the group A Streptococcus. Such a 34 
pneumococcal protein was shown to play a significant role in both 35 
nasopharyngeal colonization and development of pneumonia using murine 36 
infection models. Moreover, it was shown to repress the expression of several 37 
genes located within the rlrA pathogenicity islet. The pneumococcal R6 strain, 38 
which derives from the D39 clinical isolate, lacks the rlrA islet but has a gene 39 
(herein named mgaSpn) equivalent to the sp1800 gene. In this work, and using 40 
in vivo approaches, we have identified the promoter of the mgaSpn gene 41 
(Pmga) and demonstrated that four neighbouring open reading frames of 42 
unknown function (spr1623 to spr1626) constitute an operon. Transcription of 43 
this operon is under the control of two promoters (P1623A and P1623B) that are 44 
divergent from the Pmga promoter. Furthermore, we have shown that the 45 
MgaSpn protein activates the P1623B promoter in vivo. This activation requires 46 
sequences located around 50-120 nucleotides upstream of the P1623B 47 
transcription start site. By DNase I footprinting assays, we have also 48 
demonstrated that such a region includes an MgaSpn binding site. This is the 49 
first report on the activator role of the pneumococcal Mga-like protein. 50 
 51 
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INTRODUCTION 52 
During infection, pathogenic bacteria must be able to survive in different niches 53 
of their hosts. This adaptation requires a coordinated regulation in the expression of 54 
many virulence and metabolic genes. Global transcriptional regulators that respond to 55 
specific environmental signals (response regulators) are key elements in such 56 
regulatory networks. One example is the Mga protein of the Gram-positive (G+) 57 
bacterium Streptococcus pyogenes (group A Streptococcus, GAS), which causes a 58 
broad spectrum of diseases in humans (3). To date, very little is known about how 59 
Mga (multiple gene regulator of GAS) is able to sense changes in the environment. 60 
However, its role in pathogenesis has been studied in detail (12, 23). During 61 
exponential growth, Mga activates directly the transcription of several virulence 62 
genes, including its own gene. These Mga-regulated genes encode proteins that 63 
enable the bacterium to colonize specific host tissues and evade the host immune 64 
response. In addition, a transcriptome analysis revealed that Mga activates or 65 
represses, likely in an indirect way, the expression of various genes involved in the 66 
transport and utilization of sugars and other metabolites (30). Homologues of Mga 67 
have been identified in several G+ pathogens, including S. dysgalactiae (5, 38), S. 68 
pneumoniae (9) and Bacillus anthracis (35).  69 
S. pneumoniae (the pneumococcus) remains a main cause of morbidity and 70 
mortality worldwide. It usually resides in the nasopharynx of healthy individuals. 71 
However, when the immune system weakens, S. pneumoniae can cause serious 72 
diseases, such as pneumonia, meningitis and septicemia (15, 37). The genomic 73 
sequence of the TIGR4 strain (a serotype 4 clinical isolate) revealed that about 5% of 74 
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this genome is composed of insertion sequences that may contribute to genome 75 
rearrangements through uptake of foreign DNA (34). Signature-tagged mutagenesis 76 
experiments in TIGR4 led to the identification of several genes associated with 77 
virulence (8). One of them was the sp1800 gene that is highly conserved in the 78 
pneumococcal strains whose genome has been totally or partially sequenced. The 79 
sp1800 gene encodes a protein named MgrA (Mga-like repressor A) due to its 80 
homology to the Mga response regulator of GAS (9). MgrA (493 amino acids) was 81 
shown to play a significant role in both nasopharyngeal colonization and development 82 
of pneumonia in murine infection models (9). Furthermore, microarray experiments 83 
showed that MgrA is able to repress the expression of several genes located within 84 
the rlrA pathogenicity islet (9). Contrary to the sp1800 gene, the rlrA islet has been 85 
found in a small number of pneumococcal strains (27), indicating that it might not be 86 
the main target of the MgrA regulator (9). This fact suggested that novel MgrA-87 
regulated genes could be identified working with different pneumococcal strains 88 
and/or under different bacterial growth conditions. Indeed, there is evidence that 89 
some response regulators influence the transcriptional profile in a different manner 90 
depending on the bacterial strain and/or serotype (10, 11, 22, 30). 91 
The genome of the pneumococcal R6 strain, which derives from the D39 clinical 92 
isolate (serotype 2), has been totally sequenced. Unlike the TIGR4 strain, R6 and 93 
D39 lack the rlrA pathogenicity islet (14, 20, 34). The spr1622 gene (herein named 94 
mgaSpn) of the R6 strain encodes a protein (MgaSpn) that differs from the MgrA 95 
regulator in two amino acid residues. In the present work, we have identified the 96 
promoter of the mgaSpn gene (Pmga). Upstream of this promoter there are four open 97 
reading frames (ORFs) of unknown function (spr1623 to spr1626) that are highly 98 
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conserved in the TIGR4 strain. We have demonstrated that these ORFs are 99 
transcribed into a single polycistronic mRNA molecule from two promoters (P1623A 100 
and P1623B) that are divergent from the Pmga promoter. Moreover, unlike previous 101 
studies in TIGR4 (9), we show here that MgaSpn activates the P1623B promoter in 102 
vivo. This activation requires sequences that are recognized by a His-tagged MgaSpn 103 
protein in vitro. Hence, our findings show, for the first time, that the pneumococcal 104 
Mga-like regulator has a positive effect on gene expression. 105 
 106 
MATERIALS AND METHODS 107 
Bacterial strains, oligonucleotides and plasmids. The S. pneumoniae R6 108 
strain was used (14). To construct the R6Δmga mutant strain, gene replacement by 109 
homologous recombination was carried out. A 1,165-bp DNA fragment that contained 110 
the pC194 cat gene (chloramphenicol resistance) (13) was flanked by R6 DNA 111 
sequences (543-bp and 605-bp, respectively). In the R6 genome, such DNA 112 
sequences are flanking the mgaSpn gene (promoter plus coding sequence). The cat 113 
cassette generated in vitro was used to transform competent R6 cells. Selection of 114 
transformants resistant to chloramphenicol (1.5 µg/ml) led to the isolation of the 115 
R6Δmga strain. Dye-terminator sequencing at Secugen (CIB, Madrid) confirmed that 116 
R6Δmga lacks the chromosomal region that spans the 1596826 and 1598431 117 
coordinates.  118 
Oligonucleotides used are listed in Table 1. Plasmids pAS, pAST and pAS-119 
T2T1rrnB (herein named pAST2), which are based on the pMV158 replicon, were 120 
used (32). They carry the tetL gene (tetracycline resistance). Plasmid pDL287, a 121 
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pVA380-1 derivative that carries a kanamycin resistance gene, was also used (21). 122 
To construct pAS-Pmga, a 170-bp region of the R6 genome (promoter Pmga) was 123 
amplified by PCR using the PrSp1 and PrSp2 primers. The amplified DNA was 124 
digested with BamHI, and the 142-bp digestion product was inserted into the BamHI 125 
site of pAS. In pAS-Pmga, gfp expression is under the control of the Pmga promoter. 126 
To construct pAST-PAB and pAST2-Pmga, a 333-bp region of the R6 DNA was 127 
amplified with the PmgaSac and PABSac primers. After SacI digestion, the 301-bp 128 
restriction fragment (promoters P1623A, P1623B and Pmga) was cloned into the SacI 129 
site of pAST (pAST-PAB; gfp expression under the control of the P1623A and 130 
P1623B promoters) and pAST2 (pAST2-Pmga; gfp expression under the control of 131 
the Pmga promoter). To construct pAST-PABΔ84, a 246-bp region of the R6 DNA 132 
(promoters P1623A and P1623B), was amplified with the PABSac and PABΔ84Sac 133 
primers. The PCR product was digested with SacI, and the 216-bp restriction 134 
fragment was inserted into the SacI site of pAST. To construct pAST-PABΔ153, a 135 
177-bp region of the R6 DNA (promoters P1623A and P1623B), was amplified with 136 
the PABSac and PABΔ153Sac primers. After SacI digestion, the 146-bp restriction 137 
fragment was cloned into the SacI site of pAST. In pAST-PABΔ84 and pAST-138 
PABΔ153, gfp expression is under the control of the P1623A and P1623B promoters. 139 
Construction of the pDLPsulA::mga plasmid was as follows: (i) amplification of a 189-140 
bp region of the R6 DNA (promoter PsulA) (32) using the PsulNde and PsulCla 141 
primers. The PCR-synthesized DNA was digested with NdeI, generating the 172-bp 142 
PsulA fragment, (ii) amplification of a 1,650-bp region of the R6 DNA (promoter-less 143 
mgaSpn gene) using the mgaNde and mgaCla primers. After digestion with NdeI, the 144 
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1,636-bp restriction fragment was ligated to the 172-bp PsulA fragment (PsulA::mga 145 
fusion gene), and (iii) amplification of the PsulA::mga fusion gene with the PsulCla 146 
and mgaCla primers. After digestion with ClaI, the 1,777-bp restriction fragment was 147 
cloned into the ClaI site of plasmid pDL287 (21).  148 
Growth and transformation of bacteria. S. pneumoniae was grown in AGCH 149 
medium (17, 32) supplemented with 0.2% yeast extract and 0.3% sucrose. For 150 
plasmid-harbouring cells, the medium was supplemented with tetracycline (1 µg/ml) 151 
and/or kanamycin (50 µg/ml). Experiments were performed at 37ºC. Procedures for 152 
competence development and transformation of S. pneumoniae were reported (19). 153 
Isolation of DNA and RNA. Genomic DNA from S. pneumoniae was prepared 154 
as described (17). For small-scale preparations of plasmid DNA, the High Pure 155 
Plasmid Isolation Kit (Roche Applied Science) was used (32). The Aurum Total RNA 156 
Mini Kit (BioRad) was used to isolate total RNA from S. pneumoniae. Cells were 157 
grown to an optical density at 650 nm (OD650) of 0.3. Then, cultures were processed 158 
as specified by the supplier, except that cells were resuspended in buffer L (50 mM 159 
Tris-HCl, pH 7.6, 1 mM EDTA, 50 mM NaCl, 0.1% deoxycholate) and incubated at 160 
30ºC for 10 min. DNA and RNA concentrations were determined using a NanoDrop 161 
ND-1000 Spectrophotometer (BioRad). 162 
Polymerase chain reaction (PCR) conditions. The Phusion High-Fidelity DNA 163 
Polymerase (Finnzymes) and the Phusion HF Buffer were used. Reaction mixtures 164 
(50 µl) contained 5-30 ng of template DNA, 20 pmol of each primer, 200 µM of each 165 
dNTP and 1 unit of DNA polymerase. PCR conditions were reported previously (32). 166 
PCR products were purified with the QIAquick PCR Purification Kit (QIAGEN). 167 
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Primer extension of total RNA. The ThermoScript Reverse Transcriptase 168 
enzyme (Invitrogen) was used. Primers were 32P-labeled at the 5´-end with [γ-32P]-169 
ATP (3000 Ci/mmol; PerkinElmer) and T4 polynucleotide kinase (New England 170 
Biolabs). Non-incorporated nucleotide was removed using MicroSpin G-25 columns 171 
(GE Healthcare). In assays with non-radiolabeled primers, [α-32P]-dATP (3000 172 
Ci/mmol; Hartmann) was used in the extension reactions. Reaction mixtures (20 µl) 173 
contained ∼2 µg of total RNA and 1-2 pmol of primer. To anneal the primer with the 174 
transcript, samples were incubated at 65ºC for 5 min. Extension reactions were 175 
carried out at 58ºC for 60 min. After heating at 85ºC for 5 min, samples were ethanol-176 
precipitated, and dissolved in loading buffer (80% formamide, 1 mM EDTA, 10 mM 177 
NaOH, 0.1% bromophenol blue, 0.1% xylene cyanol). cDNA products were analyzed 178 
by sequencing gel (8 M urea-6% polyacrylamide) electrophoresis. Dideoxy-mediated 179 
chain-termination sequencing reactions were run in the same gel. Labeled products 180 
were visualized using a Fujifilm Image Analyzer FLA-3000. The intensity of the bands 181 
was quantified using the QuantityOne software (BioRad). 182 
RT-PCR assays. For first-strand cDNA synthesis, 20 pmol of primer were 183 
annealed to ∼1.5 µg of total RNA. The mixture was incubated with 15 units of 184 
ThermoScript Reverse Transcriptase (Invitrogen) at 55ºC for 45 min. PCRs were then 185 
carried out using cDNA as template (10% of the first-strand reaction), 20 pmol of each 186 
primer and the Phusion High-Fidelity DNA Polymerase (see PCR conditions). To rule 187 
out the presence of genomic DNA in the RNA preparation, the same reactions were 188 
performed in the absence of the reverse transcriptase. As positive control, PCRs 189 
were performed with genomic DNA. PCR-products were analyzed by agarose (0.8%) 190 
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gel electrophoresis. Gels were stained with ethidium bromide and DNA was 191 
visualized using a Gel-Doc system (Bio-Rad). 192 
Fluorescence assays. Plasmid-carrying cells were grown to an OD650 of 0.3. 193 
Fluorescence intensity was measured as reported (32) using a Thermo Scientific 194 
Varioskan Flash instrument (excitation at 488 nm and emission at 515 nm). In each 195 
case, three independent cultures were analyzed. The fluorescence corresponding to 196 
200 µl of PBS buffer without cells was around 0.03 arbitrary units.  197 
Western blots. Cells were grown to an OD650 of 0.3. The protocol used to 198 
prepare whole-cell extracts was described previously (32). Total proteins were 199 
separated by SDS-polyacrylamide (10%) gel electrophoresis. Proteins were 200 
transferred electrophoretically to Immun-blot PVDF membranes (BioRad) using a Mini 201 
Trans Blot (Bio-Rad) as reported (32). Membranes were probed with polyclonal 202 
antibodies against His-tagged MgaSpn. Antigen-antibody complexes were detected 203 
using anti-rabbit horseradish peroxidase-conjugated antibodies, the Immun-StarTM 204 
HRP Substrate Kit (BioRad), and the Luminescent Image Analyzer LAS-3000 (Fujifilm 205 
Life Science). The intensity of the bands was quantified using the QuantityOne 206 
software (BioRad). 207 
Overproduction and purification of MgaSpn-His. Gene mgaSpn was 208 
engineered to encode a His-tagged MgaSpn protein (MgaSpn-His). A 1,512-bp region 209 
of the R6 genome was amplified by PCR using the 1622Nde and 1622Xho-His 210 
oligonucleotides, which include a single restriction site for NdeI and XhoI, respectively 211 
(Table 1). The amplified DNA was digested with both enzymes, and the 1,481-bp 212 
digestion product was cloned into the pET24b vector (Novagen), which enables a C-213 
terminal His6-tag fusion. E. coli BL21(DE3) cells harboring plasmid pET24b-mgaSpn-214 
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His were grown at 37ºC in tryptone-yeast extract medium containing kanamycin (30 215 
µg/ml). When the culture reached an OD600 of 0.45, isopropyl-β-D-216 
thiogalactopyranoside (IPTG) was added (1 mM). After 25 min, cells were incubated 217 
with rifampicin (200 µg/ml) for 60 min. Cells were then sedimented, washed twice with 218 
buffer V-His (10 mM Tris-HCl, pH 7.6, 5% glycerol, 300 mM NaCl, 5 mM β-219 
mercaptoethanol), and stored at –80ºC. The cell pellet was concentrated (40x) in 220 
buffer V-His containing an EDTA-free protease inhibitor cocktail (Roche). Cells were 221 
disrupted by passage through a French pressure cell, and the whole-cell extract was 222 
centrifuged to remove cell debris. Imidazole (10 mM) was added to the clarified 223 
extract, which was loaded onto a HisTrap HP column (GE Healthcare) pre-224 
equilibrated with buffer V-His containing 10 mM imidazole. After washing with the 225 
same buffer, MgaSpn-His was eluted with buffer V-His containing 250 mM imidazol. 226 
Fractions containing MgaSpn-His were identified by Coomassie-stained SDS-227 
polyacrylamide (10%) gels, pooled, and dialyzed against buffer P (20 mM Tris-HCl, 228 
pH 7.6, 5% glycerol, 250 mM NaCl, 1 mM EDTA, 1 mM DTT). The protein preparation 229 
was concentrated by filtering through a 10 kDa cut-off membrane (Macrosep, Pall), 230 
loaded onto a HiLoad Superdex 200 gel-filtration column (Amersham), and subjected 231 
to fast-pressure liquid chromatography (FPLC; Biologic DuoFlow, BioRad). Fractions 232 
containing MgaSpn-His were pooled, concentrated and stored at -80ºC. Protein 233 
concentration was determined using a NanoDrop ND-1000 Spectrophotometer 234 
(BioRad). 235 
DNase I footprinting assays. A 222-bp region of the R6 genome (coordinates 236 
1598298-1598519) was amplified by PCR using the 1622I and 1622H primers. One of 237 
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the primers was previously 32P-labeled at the 5´-end using [γ-32P]-ATP (3,000 238 
Ci/mmol; PerkinElmer) and T4 polynucleotide kinase. Reaction mixtures (10 µl) 239 
contained 30 mM Tris-HCl, pH 7.6, 1.2 mM DTT, 0.2 mM EDTA, 1 mM CaCl2, 10 mM 240 
MgCl2, 50 mM NaCl, 1% glycerol, 4 nM of the 32P-labeled 222-bp DNA and different 241 
concentrations of MgaSpn-His. After 20 min at room temperature, 0.04 units of 242 
DNase I (Roche Applied Science) were added for 5 min at the same temperature. 243 
Reactions were stopped with 1 µl of 250 mM EDTA. Then, 4 µl of loading buffer (80% 244 
formamide, 1 mM EDTA, 10 mM NaOH, 0.1% bromophenol blue and 0.1% xylene 245 
cyanol) were added. Samples were heated at 95°C for 5 min, and loaded on 8 M 246 
urea-6% polyacrylamide gels. Dideoxy-mediated chain termination sequencing 247 
reactions using the 222-bp fragment and either the 1622I or the 1622H 248 
oligonucleotide were run in the same gel. Labeled products were visualized using a 249 
Fujifilm Image Analyzer FLA-3000 or by autoradiography. The intensity of the bands 250 
was quantified using the QuantityOne software (BioRad). 251 
 252 
RESULTS 253 
Transcription of the mgaSpn gene in pneumococcal R6 cells. The complete 254 
genome sequence of S. pneumoniae R6 has been published (14) (GenBank 255 
AE007317.1). The ATG codon at coordinate 1598270 is likely the translation start site 256 
of the spr1622 gene (herein named mgaSpn), since it is preceded by a putative 257 
Shine-Dalgarno sequence (5´-AAAGAGAGAAAG-3´) (Fig.1) that complies with the 258 
reported consensus sequence for pneumococcus 259 
(http://www.changbioscience.com/biotoolkit2.html). Translation from this ATG codon 260 
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would produce a protein of 493 residues (MgaSpn). EMBOSS needle global 261 
sequence alignment (31) of MgaSpn and the Mga regulator (530 residues) encoded 262 
by the M6_Spy1720 gene of S. pyogenes MGAS10394 revealed a 42.6% of similarity 263 
and a 21.4% of identity. 264 
To examine whether the mgaSpn gene was transcribed, RT-PCR experiments 265 
were carried out (Fig. 2). The 1622A oligonucleotide was used as primer for extension 266 
on total RNA isolated from R6 cells. The cDNA products were further amplified by 267 
PCR using either the 1622A and C1622D or the 1622A and 1622C primers. As 268 
controls, PCR reactions were performed using total RNA (negative control) or 269 
genomic DNA (positive control) as templates. With the 1622A and C1622D primers, a 270 
PCR-product that migrated at the position expected for a 1,023-bp DNA was 271 
synthesized. Such a product was not visualized in the negative control. With the 272 
1622A and 1622C primers, no PCR-products were detected. However, a product with 273 
the mobility expected for a 1,221-bp fragment was synthesized in the positive control. 274 
Therefore, transcription of the mgaSpn gene was initiated at a site located 275 
downstream of coordinate 1598452. Sequence analysis of the region spanning this 276 
coordinate and the translation start codon of the mgaSpn gene revealed the existence 277 
of a putative promoter (herein named Pmga) (Fig. 1). It has a consensus –10 278 
hexamer (5´-TATAAT-3´), a consensus –10 extension (5´-TGTG-3´) and shows a 3/6 279 
match at the –35 hexamer (5´-ATGCTA-3´) (consensus residues are shown in bold). 280 
The –35 and –10 elements are separated by 16 nucleotides. The features of the 281 
Pmga promoter indicate that it would be likely recognized by a housekeeping σ factor 282 
similar to the Escherichia coli σ70 (7).  283 
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We next performed primer extension assays using RNA from R6 cells and the 284 
1622D primer, which is complementary to the C1622D oligonucleotide (see Fig. 2). 285 
No cDNA products were detected (not shown), which indicated that the amount of 286 
mgaSpn transcripts in the RNA preparation was small. To amplify the signal, a 136-bp 287 
chromosomal region (coordinates 1598440 to 1598305), which contained the putative 288 
Pmga promoter, was inserted into the BamHI site of the pAS vector (plasmid pAS-289 
Pmga; Fig. 3). This site is located upstream of a promoter-less gfp allele that encodes 290 
a variant of the green fluorescent protein (32). The intensity of fluorescence in 291 
cultures of cells carrying the pAS-Pmga plasmid was slightly higher (1.5-fold) than in 292 
cultures of cells harbouring the pAS vector, indicating that the 136-bp region 293 
contained a promoter signal. Also, primer extension assays were performed using 294 
RNA from cells carrying plasmid pAS-Pmga. As primer, the INTgfp oligonucleotide, 295 
which anneals to gfp transcripts, was used (Fig. 3). Two cDNA products of 120 and 296 
121 nucleotides were detected, indicating that transcription of the gfp gene started at 297 
a site located 7-8 nucleotides downstream of the –10 element of the Pmga promoter. 298 
Thus, the Pmga promoter was functional under our bacterial growth conditions.  299 
Transcription of the spr1623-spr1626 operon in pneumococcal R6 cells. 300 
Upstream of the mgaSpn gene there are four ORFs (spr1623-spr1626) that appeared 301 
to be organized in an operon (Fig. 1). The mgaSpn gene and the putative operon 302 
would be divergently transcribed. The ATG initiation codon of the mgaSpn gene 303 
(coordinate 1598270) and the ATG initiation codon of the spr1623 ORF (coordinate 304 
1598960) are separated by 689-bp. To investigate whether the putative operon was 305 
transcribed, RT-PCR assays were performed (Fig. 4). First, the 1623B oligonucleotide 306 
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was used as primer for extension on total RNA isolated from R6 cells. The resulting 307 
cDNA was amplified by PCR using either the 1623B and 1623C or the 1623B and 308 
1623A primers. With the 1623B and 1623C primers, a PCR-product that migrated at 309 
the position expected for a 695-bp DNA was synthesized (Fig. 4). With the 1623B and 310 
1623A primers, no PCR-products were visualized. Nevertheless, such primers 311 
amplified an 892-bp region using genomic DNA as template. Next, we performed RT-312 
PCR assays using the 1626A primer for cDNA synthesis (Fig. 4). Amplification of the 313 
cDNA with the 1626A and 1623C primers generated a product that moved at the 314 
position expected for a 1,917-bp fragment. Collectively, these results indicated that 315 
the four ORFs (spr1623-spr1626) were transcribed into a polycistronic mRNA 316 
molecule from a site(s) located between coordinates 1598433 and 1598630. 317 
Sequence analysis of this region predicted a promoter sequence (herein named 318 
P1623A; Fig.1) that has a canonical –10 hexamer (5´-TATAAT-3´) and a near 319 
consensus –35 hexamer (5´-TTGACT-3´). The spacing between both sequence 320 
elements is 17 nucleotides. 321 
To analyze whether the P1623A promoter was functional in vivo, we performed 322 
primer extension assays using the PDA oligonucleotide (Fig. 5). Two cDNA products 323 
of 106 and 191 nucleotides were detected, which would correspond to transcription 324 
initiation events at coordinates 1598592 (P1623A promoter) and 1598507, 325 
respectively. This result indicated that the pneumococcal RNA polymerase 326 
recognized not only the P1623A promoter but also a promoter sequence (named 327 
P1623B) that has a consensus –10 hexamer (5´-TATAAT-3´) but lacks a –35 element 328 
(see Fig. 1). The functionality of the P1623B promoter was confirmed further by 329 
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primer extension using the PDB oligonucleotide (cDNA product of 60 nucleotides) 330 
(Fig. 5).  331 
MgaSpn activates the P1623B promoter in vivo. To investigate whether 332 
MgaSpn influenced the activity of a particular promoter in vivo, we constructed a 333 
pneumococcal strain designed to overproduce MgaSpn. First, we constructed the 334 
PsulA::mga fusion gene, in which the Pmga promoter of the mgaSpn gene was 335 
replaced with the promoter of the pneumococcal sulA gene (PsulA) (18, 32). The 336 
fusion gene was then inserted into pDL287 (21) generating the pDLPsulA::mga 337 
recombinant. Compared to R6 plasmid-free cells (Fig. 6; lane 1) or R6 cells carrying 338 
pDL287 (not shown), the amount of MgaSpn increased ∼8-fold in cells harbouring 339 
pDLPsulA::mga (Fig. 6; lane 3). By primer extension, we analyzed the effect of the 340 
MgaSpn overproduction on the activity of the P1623A and P1623B promoters located 341 
on the bacterial chromosome. We used a mix of oligonucleotides radioactively labeled 342 
at the 5’ end: PDA (see Fig. 5) and PErpoE, which anneal to spr1623 and rpoE 343 
transcripts, respectively. The rpoE gene (spr0437 in the R6 genome) encodes the 344 
delta subunit of the RNA polymerase and was used as internal control. As shown in 345 
Figure 7, using RNA from R6/pDL287 cells (lane 1; low levels of MgaSpn), three 346 
cDNA products of 106-nt (P1623A promoter), 191-nt (P1623B promoter) and 231-nt 347 
(PrpoE promoter) were synthesized. Unlike the 231-nt product, the amount of the 348 
106-nt and 191-nt cDNAs increased 2.6-fold and 4.5-fold, respectively, when RNA 349 
from R6/pDLPsulA::mga cells was used (lane 2; overproduction of MgaSpn). 350 
Therefore, overproduction of MgaSpn led to activation of promoters P1623A and 351 
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P1623B, although the effect appeared to be higher on the activity of promoter 352 
P1623B.  353 
We next constructed an R6 derivative, named R6Δmga, in which the 354 
chromosomal region spanning the coordinates 1596826 and 1598431 was replaced 355 
with the cat gene (chloramphenicol resistance) of plasmid pC194 (13). This mutant 356 
strain lacks the mgaSpn gene (including the Pmga promoter) but conserves the 357 
P1623A and P1623B promoter sequences (see Fig. 1). As expected, R6Δmga cells 358 
did not synthesize MgaSpn (Fig. 6; lane 2). By primer extension, we examined the 359 
activity of the chromosomal P1623A and P1623B promoters in R6Δmga cells carrying 360 
either pDL287 (absence of MgaSpn) (Fig. 7; lane 3) or pDLPsulA::mga 361 
(overproduction of MgaSpn) (lane 4). Again, a mix of the 5´-labeled PDA and PErpoE 362 
primers was used. Compared to R6/pDL287 cells (lane 1; low levels of MgaSpn), the 363 
191-nt product (P1623B) was not detected in R6Δmga/pDL287 cells (lane 3; absence 364 
of MgaSpn), although no changes were found in the amount of the 106-nt (P1623A) 365 
and 231-nt (PrpoE) cDNAs. Thus, in the absence of MgaSpn the activity of the 366 
P1623B promoter decreased without affecting the activity of the P1623A promoter. 367 
However, unexpectedly, the activity of the P1623B promoter on the R6Δmga genome 368 
did not change in the presence of pDLPsulA::mga (lane 4; overproduction of 369 
MgaSpn). These results suggested that the genome of the R6Δmga strain lacked not 370 
only the mgaSpn gene (including the Pmga promoter) but also a site required for 371 
MgaSpn-mediated activation of promoter P1623B (see below).  372 
Mapping the site required for MgaSpn-mediated activation of the P1623B 373 
promoter. The promoter-probe vector pAST (32) (Fig. 8A) carries a multiple cloning 374 
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site between the T1-T2 tandem terminators of the E. coli rrnB ribosomal RNA operon 375 
and a promoter-less gfp allele. Moreover, the T1-T2 terminators (T1T2rrnB region) 376 
are located downstream of the tetL gene, which confers resistance to tetracycline 377 
(19). Transcription of the tetL gene terminates efficiently at the T1T2rrnB region (32). 378 
To delimit the site required for MgaSpn-mediated activation of the P1623B promoter, 379 
a deletion analysis was carried out. Three chromosomal regions were inserted 380 
independently into the SacI site of pAST (Fig. 8A): (i) the PAB region (coordinates 381 
1598304 to 1598600; pAST-PAB); (ii) the PABΔ84 region (coordinates 1598388 to 382 
1598600; pAST-PABΔ84) and (iii) the PABΔ153 region (coordinates 1598457 to 383 
1598600; pAST-PABΔ153). In these constructions, gfp expression was under the 384 
control of both promoters, P1623A and P1623B. Thus, the promoter activity of each 385 
chromosomal region was evaluated by fluorescence assays (Fig. 8A). The promoter 386 
activity of the PAB and PABΔ84 regions was 2-fold higher in R6 cells (low levels of 387 
MgaSpn) than in R6Δmga cells (absence of MgaSpn). However, the promoter activity 388 
of the PABΔ153 region was similar in both genetic backgrounds. These results 389 
indicated that the region spanning the coordinates 1598388 and 1598457 contained 390 
sequences that were required for MgaSpn-mediated activation of promoters P1623A 391 
and/or P1623B. 392 
The promoter activity of the PABΔ84 and PABΔ153 regions was further 393 
examined by primer extension (Fig. 9). A mix of the 5´-labeled INTgfp and ASTtetL 394 
primers was used. They anneal to gfp and tetL transcripts, respectively. The tetL 395 
gene of pAST was used as internal control. Using RNA from R6 cells (low levels of 396 
MgaSpn) harbouring pAST-PABΔ84 (Fig. 9; lane 2), three cDNA products of 102-nt 397 
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(PtetL promoter), 111-nt (P1623A promoter) and 196-nt (P1623B promoter) were 398 
synthesized. Unlike the 102-nt and 111-nt cDNAs, the amount of the 196-nt cDNA 399 
decreased 5-fold when RNA from R6 cells harbouring pAST-PABΔ153 was used 400 
(lane 3). Thus, in R6 cells (low levels of MgaSpn), deletion of the region that spans 401 
the 1598388 and 1598457 coordinates (see Fig. 8A) reduced the activity of the 402 
P1623B promoter but not the activity of the P1623A promoter. The specific decrease 403 
in the activity of promoter P1623B was also observed in R6Δmga cells (absence of 404 
MgaSpn) carrying either PABΔ84 (Fig. 9; lane 4) or PABΔ153 (lane 5). These results 405 
demonstrated that MgaSpn was able to activate, directly or indirectly, the P1623B 406 
promoter in vivo. This activation required sequences located within the region 407 
1598388-1598457 (see Fig.1 and Fig. 8A). Such a 70-bp region maps between the 408 
Pmga and P1623B divergent promoters, just 50-bp upstream of the P1623B 409 
transcription start site (coordinate 1598507). 410 
MgaSpn does not influence the activity of promoter Pmga in vivo. Plasmid 411 
pAST2 (named pAS-T2T1rrnB in (32)) carries a multiple cloning site upstream of the 412 
promoter-less gfp gene (see Fig. 8B). Compared to the promoter-probe vector pAST, 413 
pAST2 carries the T1-T2 terminators (T1T2rrnB region) inserted in the opposite 414 
orientation (T2T1rrnB region). The T2T1rrnB region functions as a transcriptional 415 
terminator signal, although it is not as efficient as the T1T2rrnB region (32). The site 416 
required for MgaSpn-mediated activation of the P1623B promoter is located around 417 
80-150 nucleotides upstream of the Pmga transcription start site (coordinate 418 
1598308). This fact suggested that MgaSpn might also influence the activity of the 419 
Pmga promoter in vivo. To test this hypothesis, the PAB chromosomal region 420 
 19 
(coordinates 1598304-1598600), which carries the P1623A, P1623B and Pmga 421 
promoters, was inserted into the SacI site of pAST2 generating the pAST2-Pmga 422 
recombinant (Fig. 8B). In this construction, gfp expression is under the control of the 423 
Pmga promoter. Fluorescence assays showed that the activity of the Pmga promoter 424 
located on pAST2-Pmga was similar in R6 and R6Δmga cells. Therefore, MgaSpn did 425 
not influence the activity of the Pmga promoter under our bacterial growth conditions. 426 
MgaSpn-His binds to a site located upstream of promoter P1623B. To 427 
determine whether MgaSpn was able to interact with the P1623B promoter region, we 428 
performed DNase I footprinting assays with a His-tagged MgaSpn protein (MgaSpn-429 
His). This variant of MgaSpn carries six additional His residues at the C-terminal end. 430 
We used a 222-bp DNA fragment (coordinates 1598298-1598519 of R6) that 431 
contained the 70-bp region (1598388-1598457) known to be required for MgaSpn-432 
mediated activation of the P1623B promoter (Fig. 10C). Such a DNA fragment was 433 
radioactively labeled either at the 5’ end of the coding strand (Fig. 10A) or at the 5’ 434 
end of the non-coding strand (Fig. 10B). On the coding strand and in the presence of 435 
MgaSpn-His, the region spanning the –52 and –90 positions relative to the 436 
transcription start site of the P1623B promoter was protected against DNase I 437 
digestion. On the non-coding strand, changes in the DNase I sensitivity (diminished 438 
cleavages) were observed from –57 to –79 and from –83 to –102. Moreover, the –82 439 
and –104 positions were slightly more sensitive to DNase I cleavage. We conclude 440 
that MgaSpn interacts with sequences located between the positions –52 and –102 441 
relative to the P1623B transcription start site (Fig. 10C). Such sequences are 442 
included within the region shown to be required for MgaSpn-mediated activation of 443 
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the P1623B promoter. Hence, the MgaSpn regulator activates directly the P1623B 444 
promoter.  445 
 446 
DISCUSSION 447 
In pathogenic bacteria, global transcriptional regulators whose activity and/or 448 
intracellular concentration change in response to external stimuli are crucial during 449 
the infection process. Some of these response regulators are associated to a 450 
membrane-bound sensor histidine kinase, the so-called two-component signal 451 
transduction systems (1, 29). Also, various ‘stand-alone’ response regulators, whose 452 
sensory elements remain unidentified, have been implicated in the regulation of 453 
virulence gene expression (23). To this class of global regulators belongs the Mga 454 
protein of GAS (12). In the G+ bacterium S. pneumoniae, several two-component 455 
systems are known to contribute to its virulence, although some of them to different 456 
extent depending on the strain and/or infection model used (26). Moreover, signature-457 
tagged mutagenesis in the pneumococcal TIGR4 strain revealed that other putative 458 
transcriptional regulators might control the expression of specific virulence genes (8). 459 
It was the case of the sp1800 gene product, an Mga orthologue that was shown to act 460 
as a repressor of the rlrA pathogenicity islet (9). Here, we have performed a 461 
transcriptional analysis of the region that spans the 1596789 and 1600589 462 
coordinates of the pneumococcal R6 genome (14). Such a region contains the 463 
spr1622 gene (mgaSpn in this work), which is equivalent to the sp1800 gene of the 464 
TIGR4 strain, and four divergent ORFs (spr1623-spr1626) that are highly conserved 465 
in TIGR4. We have identified the promoter of the mgaSpn gene (Pmga) and 466 
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demonstrated that the four ORFs constitute an operon that is transcribed from two 467 
promoters (P1623A and P1632B). Furthermore, we have shown, for the first time, that 468 
the pneumococcal Mga-like protein is able to act as a transcriptional activator: (i) 469 
MgaSpn activates the P1623B promoter in vivo and, therefore, the expression of the 470 
spr1623-spr1626 operon, (ii) this activation requires sequences located upstream of 471 
the P1623B promoter, and (iii) MgaSpn interacts with such sequences in vitro. 472 
Hemsley et al. (9) reported that the sp1800 gene product of the TIGR4 strain did not 473 
affect transcription of the neighbouring cluster of genes. This discrepancy with our 474 
results might be due to the use of different pneumococcal strains and/or to the use of 475 
different bacterial growth conditions.  476 
The pneumococcal MgaSpn regulator is homologous (42.6% similarity and 477 
21.4% identity) to the Mga regulator of GAS. In Mga, two helix-turn-helix domains 478 
were mapped near the N-terminus of the protein. Both of them are known to be 479 
required for DNA binding and transcriptional activation (24, 36). In addition, Mga is 480 
known to bind to regions located upstream of its target promoters. The position of the 481 
Mga binding site with respect to the start of transcription varies among the promoters 482 
tested (12). In the case of the MgaSpn regulator, analysis of its amino acid sequence 483 
using the Pfam database (4) revealed that it also has two putative DNA-binding 484 
domains within the N-terminal region, the so-called HTH_Mga (residues 6-65) and 485 
Mga (residues 71-158) domains. Moreover, we have shown that MgaSpn interacts 486 
with sequences located upstream of the P1623B promoter. Such sequences are also 487 
needed for MgaSpn-mediated activation of the P1623B promoter. Thus, the Mga and 488 
MgaSpn regulators might have similar DNA binding properties. 489 
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 Using the BLASTN 2.2.25+ nucleotide sequence alignment program (40), we 490 
have analyzed the region that spans the P1623A and Pmga promoters of the R6 491 
genome (see Fig. 1), which includes promoter P1623B and the MgaSpn binding site 492 
identified in this work. This analysis has revealed that such a region is identical in ten 493 
pneumococcal strains whose genome has been totally sequenced (R6, D39, TIGR4, 494 
G54, JJA, P1031, TCH8431/19A, CGSP14, Taiwan19F-14 and 70585). Furthermore, 495 
according to protein sequence database similarity searches, MgaSpn is highly 496 
conserved among the above pneumococcal strains. Compared to R6 and D39, 497 
MgaSpn has only two amino acid changes (I309M and V358I) in the TIGR4, G54, 498 
JJA, P1031, TCH8431/19A and CGSP14 strains, three amino acid changes (C280Y, 499 
I309M and V358I) in the Taiwan19F-14 strain, and three amino acid changes (I309M, 500 
V358I and P450S) in the 70585 strain. 501 
The pneumococcal R6 strain has an additional mga-like gene (spr1404). It is 502 
adjacent to the divergent spr1403 gene that encodes a collagen-like protein (PclA) 503 
(28). Both genes are absent in TIGR4 (2). Although the spr1404 gene product has 504 
homology to the MgaSpn (59.3% similarity) and Mga (40% similarity) regulators, 505 
Paterson et al. (28) reported that single deletion mutants lacking either spr1404 or 506 
spr1403 were not attenuated in a mouse model of invasive pneumoniae. Thus, as 507 
pointed out by the authors, further work is required to elucidate whether the spr1404 508 
gene has a significant role in pathogenesis. 509 
The function of the spr1623-spr1626 operon is unknown. It encodes products of 510 
188 (spr1623; hypothetical protein), 56 (spr1624; putative lipoprotein), 202 (spr1625; 511 
putative general stress protein 24) and 67 (spr1626; hypothetical protein) residues, 512 
respectively. According to the Protein Clusters database (16), the spr1624, spr1625 513 
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and spr1626 products are identical in the ten pneumococcal strains mentioned above. 514 
However, unlike R6 and D39, the operon of the other strains has an additional ORF 515 
(named sp1801 in TIGR4). It is located upstream of the equivalent spr1623 ORF and 516 
would encode a product of 54 residues (hypothetical protein, putative 517 
transglycosylase associated protein). The absence of this ORF in R6 (and D39) is 518 
due to the deletion of one nucleotide between coordinates 1598751 and 1598752, 519 
which results in a truncated ORF that would encode a product of 20 amino acids.  520 
Several observations suggest that the spr1623-spr1626 operon might play a role 521 
in virulence. First, the product (202 amino acids) of the spr1625 gene has homology 522 
(69% similarity) to the product of the Enterococcus faecalis gls24 gene (EF0080 in 523 
strain V583; 186 amino acids), which was shown to be a general stress-inducible 524 
gene involved in bile-salts resistance (6). Also, it was shown to be important for 525 
virulence using a mouse peritonitis model (33). Second, Hemsley et al. (9) reported 526 
the characterization of a TIGR4 mutant strain (STM206) that carries a transposon 527 
inserted ∼300 bp upstream of the predicted translation start codon of the sp1800 528 
gene. This mutant strain was attenuated for both nasopharyngeal carriage and lung 529 
infection in murine models. Moreover, it was much more affected in virulence than a 530 
mutant strain (AC1272) that carries a transposon inserted into the coding sequence of 531 
the sp1800 gene (mgaSpn gene in R6). Now, we have shown that the distance 532 
between the translation start codon of the mgaSpn gene (coordinate 1598270) and 533 
the transcription initiation sites of the spr1623-spr1626 operon is 323 (from the 534 
P1623A promoter; coordinate 1598592) and 238 nucleotides (from the P1623B 535 
promoter; coordinate 1598507), respectively. Hence, the transposon in strain 536 
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STM206 could be affecting the expression of the sp1801-sp1805 operon (spr1623-537 
spr1626 operon in R6). If this were the case, the attenuation phenotype of the 538 
STM206 mutant strain (Hemsley et al., 2003) would indicate an important role of the 539 
operon in pneumococcal virulence. 540 
In summary, this is the first report on the activator role of the pneumococcal 541 
Mga-like regulator (MgaSpn). This regulatory protein activates the transcription of a 542 
four-gene operon from a site located upstream of the target promoter.   543 
 544 
 545 
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FIGURE LEGENDS 688 
FIG. 1. Genetic map of the region spanning the 1596789 and 1600589 coordinates of 689 
the R6 genome (14). Gene spr1622 has been named mgaSpn in this work. For each 690 
ORF, the coordinates of the predicted start and stop codons are indicated. The 691 
nucleotide sequence of the region spanning the start codon of the mgaSpn gene 692 
(coordinate 1598270) and the start codon of the spr1623 ORF (coordinate 1598960) 693 
is shown. The putative Shine-Dalgarno sequence (SD) of mgaSpn is indicated. The 694 
main sequence elements (-35 box, -10 box and extended –10 box) of the promoters 695 
identified in this work (Pmga, P1623B and P1623A), as well as the transcription start 696 
sites (+1 position), are indicated. 697 
FIG. 2. Transcription of mgaSpn in vivo. RT-PCR assays were performed using RNA 698 
from R6 cells. The position of the oligonucleotides used (1622A, 1622C and C1622D) 699 
is shown. RT-PCR reactions (lane R) were subjected to agarose (0.8%) gel 700 
electrophoresis. RT-PCR reactions without adding the reverse transcriptase were 701 
performed as negative control (lane N). The size of PCR-amplified DNA fragments (1 702 
and 2) using genomic DNA as template (lane P, positive control) is indicated. The 703 
size (in bp) of DNA fragments (lane M) used as molecular weight markers 704 
(HyperLadder I, Bioline) is indicated on the right of the gel.  705 
FIG. 3. Promoter Pmga is functional in vivo. Primer extension reactions were carried 706 
out on total RNA isolated from R6 cells harbouring plasmid pAS-Pmga. The gfp gene 707 
carries translation initiation signals optimized for prokaryotes (SD) (25). The tetL gene 708 
confers resistance to tetracycline. The main sequence elements of the Pmga 709 
promoter (grey boxes) and the ATG initiation codon of the gfp gene (black box) are 710 
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indicated. BamHI sites are underlined. The asterisks indicate the 3´-end of the cDNA 711 
products synthesized using the INTgfp primer. The size of the cDNA products (lane 712 
R) is indicated in nucleotides on the right of the gel. Dideoxy-mediated chain-713 
termination sequencing reactions using pLS1 DNA (19) and the F-pLS1 primer (5´-714 
TGCTGGCAGGCACTGGC-3´; coordinates 802-818 of pLS1) were used as DNA size 715 
markers (lanes A, C, G, T).  716 
FIG. 4. The spr1623-spr1626 ORFs constitute an operon. RT-PCR assays were 717 
performed using RNA from R6 cells. The position of the oligonucleotides used 718 
(1623A, 1623B, 1623C and 1626A) is shown. RT-PCR reactions (lane R) were 719 
analyzed by agarose (0.8%) gel electrophoresis. As negative control (lane N), RT-720 
PCR reactions were carried out without adding the reverse transcriptase. The size of 721 
PCR-amplified DNA fragments (1, 2 and 3) using genomic DNA as template (lane P, 722 
positive control) is indicated. Lane M: DNA fragments used as molecular weight 723 
markers (in bp) (HyperLadder I, Bioline). 724 
FIG. 5. The spr1623-spr1626 operon is transcribed from promoters P1623A and 725 
P1623B. Primer extension assays were performed using RNA from R6 cells and the 726 
PDA (left gel) or PDB (right gel) primers. The size of the cDNA products (lane R) is 727 
indicated in nucleotides on the right of the gels. A, C, G, T sequence ladders were 728 
used as DNA size markers. They were prepared using M13mp18 DNA (39) and the –729 
40 M13 primer (5´-GTTTTCCCAGTCACGAC-3´) (left gel) or a PCR-amplified DNA 730 
fragment from the E. faecalis V583 genome and the Rev primer (5´-731 
GATTTCTTCAATTTGTTCCATC-3´) (right gel). The asterisks in the scheme below 732 
the gels indicate the transcription start sites identified in this study. 733 
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FIG. 6. Detection of MgaSpn in pneumococcal cell extracts by Western blotting using 734 
polyclonal antibodies against His-tagged MgaSpn. Total proteins from R6 cells (lane 735 
1), R6Δmga cells (lane 2) and pDLPsulA::mga-carrying cells (lane 3) were separated 736 
by SDS-PAGE. His-tagged MgaSpn protein (6 ng) (lane 4) and pre-stained proteins 737 
(Invitrogen) (not shown) were run in the same gel.  738 
FIG. 7. MgaSpn mediates activation of the P1623B promoter. Primer extension 739 
reactions were carried out using total RNA from R6/pDL287 (lanes 1, 5 and 6); 740 
R6/pDLPsulA::mga (lane 2); R6Δmga/pDL287 (lane 3) or R6Δmga/pDLPsulA::mga 741 
(lane 4) cells. 5´-labeled oligonucleotides were used as primers: a mix of the PDA and 742 
PErpoE primers (lanes 1, 2, 3 and 4), primer PDA (lane 5) or primer PErpoE (lane 6). 743 
The size of the cDNA products is indicated in nucleotides on the left of the gel: 106-nt 744 
(P1623A promoter), 191-nt (P1623B promoter) and 231-nt (PrpoE promoter). 745 
Sequence ladders were used as DNA size markers (lanes A, C, G, T). They were 746 
prepared using a PCR-amplified DNA fragment from the E. faecalis V583 genome 747 
and the Fw primer (5´-CGTTTGAGCAATATAATCGTTTG-3´).  748 
FIG. 8. Fluorescence assays. (A) Activity of the P1623A (PA) and P1623B (PB) 749 
promoters. The promoter-probe vector pAST was described (32). The position of the 750 
tetL (tetracycline resistance) and gfp (green fluorescence protein) genes is indicated. 751 
The T1T2 box represents the tandem terminators T1 and T2 of the E. coli rrnB 752 
ribosomal RNA operon. Grey boxes represent DNA fragments from the R6 genome. 753 
(B) Activity of the Pmga promoter. Plasmid pAST2 was described (named pAS-754 
T2T1rrnB in Ruiz-Cruz et al. (32)). Compared to pAST, it carries the T1T2rrnB region 755 
inserted in the opposite orientation (box T2T1). The position of promoter Pmga is 756 
 34 
shown. The intensity of fluorescence (arbitrary units) corresponds to 0.8 ml of culture 757 
(OD650=0.3). In each case, three independent cultures were analyzed. 758 
FIG. 9. Genomic region needed for MgaSpn-mediated activation of the P1623B 759 
promoter. Primer extension reactions were carried out using total RNA from 760 
R6/pAST-PABΔ84 (lanes 1 and 2), R6/pAST-PABΔ153 (lane 3), R6Δmga/pAST-761 
PABΔ84 (lane 4) or R6Δmga/pAST-PABΔ153 (lane 5) cells. 5´-labeled 762 
oligonucleotides were used as primers: a mix of the INTgfp and ASTtetL primers 763 
(lanes 2, 3, 4 and 5) or the ASTtetL primer (lane 1). The size of the cDNA products is 764 
indicated in nucleotides on the left of the gel: 102-nt (PtetL promoter), 111-nt (P1623A 765 
promoter) and 196-nt (P1623B promoter). Dideoxy-mediated chain-termination 766 
sequencing reactions using pAST DNA and the INTgfp primer were run in the same 767 
gel (lanes A, C, G, T). 768 
FIG. 10. DNase I footprints of MgaSpn-His-DNA complexes. The 222-bp DNA 769 
fragment (coordinates 1598298-1598519) was labeled at the 5’ end of either the 770 
coding (A) or the non-coding (B) strand. The labeled DNA (4 nM) was incubated with 771 
the indicated concentrations of MgaSpn-His. Dideoxy-mediated chain termination 772 
sequencing reactions were run in the same gel (lanes A, C, G, T). Densitometer 773 
scans corresponding to DNA without protein (grey line) and DNA with protein (black 774 
line; 240 nM in (A) and 200 nM in (B)) are shown. The MgaSpn-His-protected regions 775 
are indicated with brackets. Arrowheads indicate positions that are slightly more 776 
sensitive to DNase I cleavage. The indicated positions are relative to the transcription 777 
start site of the P1623B promoter. (C) Nucleotide sequence of the region that spans 778 
the coordinates 1598509 and 1598380 of the R6 genome. It includes the transcription 779 
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start site of the P1623B promoter (coordinate 1598507), the region required for 780 
MgaSpn-mediated activation of the P1623B promoter (1598457-1598388) and the 781 
site recognized by MgaSpn-His (brackets).  782 
 783 
784 
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 785 
 TABLE 1. Oligonucleotides used in this work. 786 
Name Sequencea (5´ to 3´) 
1622A AGTTCCTGATTGTATTCCCT 
1622C GATTCTGTATTCACGCCCTC 
1622D TTCTAATTGCCTATGACTTTTTTTAG 
C1622D CTAAAAAAAGTCATAGGCAATTAGA 
INTgfp CATCACCATCTAATTCAACAAG 
PErpoE GCCCAGCAAATACTTCTAATTCC 
ASTtetL GAGGGCAGACGTAGTTTATAGGG 
1623A GAGGGCGTGAATACAGAATC 
1623B CGTAAATTTACATGAACAGTTGGG 
1623C GGAGGGTAGGCAGTGTTGTGATC 
1626A GCACCTTCTACAGCGTCTTTAGCG 
PDA GTGATTTTACCTGCCAAGAGACC 
PDB GAAAAGTCAATTATTTCGATTG 
PrSp1 ATAAATTATCGGATCCAACCTCTTGC 
PrSp2 GAATTTGATTCTGGATCCACGCCCTC 
PmgaSac CTTTATAAATTATGAGCTCAAACCTCTTGC 
PABSac ATATCAAAAAATCGAGCTCTTTGATTATTAC 
PABΔ84Sac ATTTCGTATAAGAGCTCTACGGAGACAATATA 
PABΔ153Sac GAATACAGAATCGAGCTCAAGTCTAAAG 
PsulNde CAAGGATTTTCATCATATGATTTTTC 
PsulCla ACTGATTGTTAATCGATTTGCTTTCTGT 
mgaNde TGCAAGAGGTTTCATATGATAATTTATAAAG 
mgaCla GTACATTTTTCTTAATCGATTGAAGGTCTTTTC 
1622Nde 
1622Xho-His 
1622H 
1622I 
GAGAGAAAGATACATATGAGAGATTTA 
TTTTGTTATTTTCTCGAGCTCATCTAATCG 
CGGATTAAACCTCTTGCAATTATACC 
CAAATTCTTTAATTGTTGCTATTA 
 aBase changes that generate restriction sites (in bold) are underlined. 787 
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